Author Archives: yun

Immunotherapy for Nasopharyngeal Carcinoma

Original Investigation Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma Hai-Qiang Mai, MD, PhD; Qiu-Yan Chen, MD, PhD; Dongping Chen, MD; Chaosu Hu, PhD; Kunyu Yang, MD, PhD; Jiyu Wen, BS; Jingao Li, MD, PhD; Yingrui Shi, PhD; Feng Jin, MD; Ruilian Xu, MD; Jianji Pan, PhD; Shenhong Qu, MD; Ping Li, MD, PhD; Chunhong Hu, PhD; Yi-Chun Liu, MD; Yi Jiang, MD; Xia He, MD, PhD; Hung-Ming Wang, MD; Wan-Teck Lim, MBBS; Wangjun Liao, MD, PhD; Xiaohui He, MD; Xiaozhong Chen, MD; Siyang Wang, PhD; Xianglin Yuan, MD; Qi Li, PhD; Xiaoyan Lin, PhD; Shanghua Jing, MD; Yanju Chen, MD; Yin Lu, MD; Ching-Yun Hsieh, MD; Muh-Hwa Yang, MD, PhD; Chia-Jui Yen, MD, PhD; Jens Samol, MD; Xianming Luo, MD; Xiaojun Wang, MS; […]

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Showcase Expansive Portfolio of Hematology/Oncology Data at the 65th American Society of Hematology Annual Meeting and Exposition

Oral Presentations Abstract andSession No. Title Presentation Date/Time            Abstract 181(Session 624) Nivolumab-AVD Is Better Tolerated andImproves Progression-Free SurvivalCompared to Bv-AVD in Older Patients(Aged ≥60 Years) with Advanced StageHodgkin Lymphoma Enrolled on SWOGS1826 Clinically Relevant Abstract Saturday, December 9, 2023:2:00 PM PT Abstract 308(Session 627) Improved Survival of R/R Double Hit/TripleHit Lymphoma in the Era of […]

Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study

Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. 2019;13(2):1449–55. PubMed  Google Scholar  Cockwell Paul, Fisher Lori-Ann. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. Google Scholar  […]

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study

Collaborators GCD. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in;195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (vol 392, pg 1736, 2018). Lancet. 2018;392(10160):2170. Google Scholar  Fuchs A, Kuhl JT, Sigvardsen PE, Afzal S, Knudsen AD, Moller […]

Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–e639. https://doi.org/10.1161/CIR.0000000000001052. Epub 2022 Jan 26. Erratum in: Circulation. 2022;145(8):e153-e639. doi:10.1161/CIR.0000000000001052. Article  PubMed  Google Scholar  GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 Diseases and […]

Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?

Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):59–60. https://doi.org/10.1056/NEJMOA020245. Article  Google Scholar  Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 2010;322(13):882–9. https://doi.org/10.1056/NEJM199003293221303. Article  Google Scholar  Yousufuddin […]

3D Printing in Healthcare Market to Reach Value of $7.47 Billion by 2030: Coherent Market Insights

Burlingame, Nov. 28, 2023 (GLOBE NEWSWIRE) — According to Coherent Market Insights, The global 3D Printing in Healthcare market was valued at US$ 1.87 Billion in 2022 and is forecast to reach a value of US$ 7.47 Billion by 2030 at a CAGR of 19.0% between 2023 and 2030. Recent advances of 3D printing in healthcare […]

Global Infectious Disease Diagnostics Market Size To Worth USD 38.02 Billion By 2032

New York, United States, Nov. 28, 2023 (GLOBE NEWSWIRE) — The Global Infectious Disease Diagnostics Market Size is to Grow from USD 22.47 Billion in 2022 to USD 38.02 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/2552 Infectious disease diagnostics involve […]